Cargando…

Recent translational research: stem cells as the roots of breast cancer

Common phenotypes of cancer and stem cells suggest that breast cancers arise from stem cells. Breast epithelial cells with stem cell phenotypes have been shown to be more susceptible to immortalization and neoplastic transformation. Breast tumor stem cells with CD44(+)/CD24(-/low)Lineage(- )markers...

Descripción completa

Detalles Bibliográficos
Autor principal: Chang, Chia-Cheng
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413993/
https://www.ncbi.nlm.nih.gov/pubmed/16524453
http://dx.doi.org/10.1186/bcr1385
_version_ 1782127099346157568
author Chang, Chia-Cheng
author_facet Chang, Chia-Cheng
author_sort Chang, Chia-Cheng
collection PubMed
description Common phenotypes of cancer and stem cells suggest that breast cancers arise from stem cells. Breast epithelial cells with stem cell phenotypes have been shown to be more susceptible to immortalization and neoplastic transformation. Breast tumor stem cells with CD44(+)/CD24(-/low)Lineage(- )markers have been isolated. The role of these cells in tumor progression and clinical outcome is not clear. The relationship between breast stem cell and tumor stem cell may be elucidated by further studies of carcinogenesis of nonadherent mammosphere cells with stem cell features and by derivation of CD44(+)/CD24(-/low )cells from an adherent breast epithelial stem cell type.
format Text
id pubmed-1413993
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-14139932006-03-27 Recent translational research: stem cells as the roots of breast cancer Chang, Chia-Cheng Breast Cancer Res Commentary Common phenotypes of cancer and stem cells suggest that breast cancers arise from stem cells. Breast epithelial cells with stem cell phenotypes have been shown to be more susceptible to immortalization and neoplastic transformation. Breast tumor stem cells with CD44(+)/CD24(-/low)Lineage(- )markers have been isolated. The role of these cells in tumor progression and clinical outcome is not clear. The relationship between breast stem cell and tumor stem cell may be elucidated by further studies of carcinogenesis of nonadherent mammosphere cells with stem cell features and by derivation of CD44(+)/CD24(-/low )cells from an adherent breast epithelial stem cell type. BioMed Central 2006 2006-02-24 /pmc/articles/PMC1413993/ /pubmed/16524453 http://dx.doi.org/10.1186/bcr1385 Text en Copyright © 2006 BioMed Central Ltd
spellingShingle Commentary
Chang, Chia-Cheng
Recent translational research: stem cells as the roots of breast cancer
title Recent translational research: stem cells as the roots of breast cancer
title_full Recent translational research: stem cells as the roots of breast cancer
title_fullStr Recent translational research: stem cells as the roots of breast cancer
title_full_unstemmed Recent translational research: stem cells as the roots of breast cancer
title_short Recent translational research: stem cells as the roots of breast cancer
title_sort recent translational research: stem cells as the roots of breast cancer
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413993/
https://www.ncbi.nlm.nih.gov/pubmed/16524453
http://dx.doi.org/10.1186/bcr1385
work_keys_str_mv AT changchiacheng recenttranslationalresearchstemcellsastherootsofbreastcancer